Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

13.46
Delayed Data
As of Sep 02
 +0.48 / +3.70%
Today’s Change
5.34
Today|||52-Week Range
19.43
+120.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash--195.3M142.3M278.1M
 
 
 
 
Short Term Investment Cash-30.3M34.0M-52.7M135.8M
 
 
 
 
 
Cash & Short Term Investments161.3M195.3M142.3M278.1M
 
 
 
 
 
 
ReceivablesReceivables1.3M2.1M3.2M5.8M
 
 
 
 
 
 
InventoriesInventories1.3M703.0K3.0M2.9M
 
 
 
 
 
 
Current AssetsOther Current Assets2.4M2.6M2.3M4.2M
 
 
 
 
 
Current Assets166.3M200.7M150.8M291.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross45.6M48.8M56.6M63.3M
 
 
 
 
 
Depreciation-34.0M-38.0M-42.2M-47.0M
 
 
 
 
 
Other Assets174.0K217.0K213.0K6.5M
 
 
 
 
 
Total Assets180.3M213.6M165.3M313.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.4M4.5M4.8M8.1M
 
 
 
 
 
Short Term Debt0.000.000.007.9M
 
 
Accrued Expenses4.2M5.6M6.2M9.9M
 
 
 
 
 
Other Current Liabilities7.6M8.1M9.1M10.9M
 
 
 
 
 
Other Liabilities16.3M19.2M21.3M35.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.00191.8M
 
 
Other Liabilities3.8M3.6M3.7M4.0M
 
 
 
 
 
Total Liabilities96.4M91.7M89.6M278.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity83.9M121.8M75.7M35.1M
 
 
 
 
 
Total Shareholder Equity83.9M121.8M75.7M35.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding77.8M84.7M85.9M86.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.